peptides

  • HELP-4H

    HELP-4H

    Amount: 1 mg Application: Drug delivery Category: Cell-Penetrating Peptides Condition / Topic: Cancer, Gene therapy Layout: Freeze-dried in plastic vial Organism: Artificial Protein Name: CPP Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-GLGTLLTLLHFLLHHLLHFLKRKRQQ-NH2

  • HER2 (erbB-2)  435-443, ILHNGAYSL

    HER2 (erbB-2) 435-443, ILHNGAYSL

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Breast cancer Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Human Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-ILHNGAYSL-OH Specifications: 9mer peptide as TFA salt

  • HER2 (erbB-2)  654-662, IISAVVGIL

    HER2 (erbB-2) 654-662, IISAVVGIL

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Breast cancer, Ovarian cancer Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Human Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-IISAVVGIL-OH Specifications: 9mer peptide as TFA salt

  • HER2 (erbB-2)  665-673, VVLGVVFGI

    HER2 (erbB-2) 665-673, VVLGVVFGI

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Immunogenic Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Human Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-VVLGVVFGI-OH Specifications: 9mer peptide as TFA salt

  • Heterogeneous nuclear ribonucleoprotein Q  244-252, RLFVGSIPK

    Heterogeneous nuclear ribonucleoprotein Q 244-252, RLFVGSIPK

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Arthritis Layout: Freeze-dried in glass vial Organism: Human Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-RLFVGSIPK-OH Specifications: 9mer peptide as TFA salt

  • HEV (ORF2)

    HEV (ORF2)

    Amount: 25 μg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells) Application: T-cell immunity Category: PepMix Peptide Pools, PepMix Peptide Pools Infections Condition / Topic: Hepatitis, Infection Layout: Freeze-dried in glass vial Organism: Hepatitis E Virus (HEV) Protein Name: Capsid protein Purity: >70% (HPLC-MS), Development Grade: each peptide purified…

  • HEV (ORF3)

    HEV (ORF3)

    Amount: 25 μg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells) Application: T-cell immunity Category: PepMix Peptide Pools, PepMix Peptide Pools Infections Condition / Topic: Hepatitis, Infection Layout: Freeze-dried in glass vial Organism: Hepatitis E Virus (HEV) Protein Name: Uncharacterized protein Purity: >70% (HPLC-MS), Development Grade: each peptide purified…

  • HHV 3 (VZV, strain Dumas) Envelope glycoprotein E 121-135, SAQEDLGDDTGIHVI

    HHV 3 (VZV, strain Dumas) Envelope glycoprotein E 121-135, SAQEDLGDDTGIHVI

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Herpes zoster Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Varicella-zoster virus (VZV) Protein Name: Envelope glycoprotein Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-SAQEDLGDDTGIHVI-OH Specifications: 15mer peptide as TFA salt

  • HHV 3 (VZV, strain Dumas) Envelope glycoprotein E 46-65, DTNSVYEPYYHSDHAESSWV

    HHV 3 (VZV, strain Dumas) Envelope glycoprotein E 46-65, DTNSVYEPYYHSDHAESSWV

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Herpes zoster Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Varicella-zoster virus (VZV) Protein Name: Envelope glycoprotein Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-DTNSVYEPYYHSDHAESSWV-OH Specifications: 20mer peptide as TFA salt

  • HHV 3 (VZV, strain Dumas) Envelope glycoprotein I 136-155, PGINDAGVYVLLVRLDHSRS

    HHV 3 (VZV, strain Dumas) Envelope glycoprotein I 136-155, PGINDAGVYVLLVRLDHSRS

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Herpes zoster Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Varicella-zoster virus (VZV) Protein Name: Envelope glycoprotein Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-PGINDAGVYVLLVRLDHSRS-OH Specifications: 20mer peptide as TFA salt

  • HHV 3 (VZV, strain Dumas) RIR2 157-169, LIEGIFFVSSFAA

    HHV 3 (VZV, strain Dumas) RIR2 157-169, LIEGIFFVSSFAA

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Herpes zoster Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Varicella-zoster virus (VZV) Protein Name: Ribonucleoside-diphosphate reductase Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-LIEGIFFVSSFAA-OH Specifications: 13mer peptide as TFA salt

  • HHV 3 (VZV, strain Dumas) RIR2 165-177, SSFAAIAYLRNNG

    HHV 3 (VZV, strain Dumas) RIR2 165-177, SSFAAIAYLRNNG

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Herpes zoster Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Varicella-zoster virus (VZV) Protein Name: Ribonucleoside-diphosphate reductase Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-SSFAAIAYLRNNG-OH Specifications: 13mer peptide as TFA salt

  • HHV 3 (VZV, strain Dumas) RIR2 57-69, FIFTFLSAADDLV

    HHV 3 (VZV, strain Dumas) RIR2 57-69, FIFTFLSAADDLV

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Herpes zoster Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Varicella-zoster virus (VZV) Protein Name: Ribonucleoside-diphosphate reductase Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-FIFTFLSAADDLV-OH Specifications: 13mer peptide as TFA salt

  • HHV 3 (VZV, strain Dumas) RIR2 85-97, IHHYYIEQECIEV

    HHV 3 (VZV, strain Dumas) RIR2 85-97, IHHYYIEQECIEV

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Herpes zoster Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Varicella-zoster virus (VZV) Protein Name: Ribonucleoside-diphosphate reductase Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-IHHYYIEQECIEV-OH Specifications: 13mer peptide as TFA salt

  • HHV 3 (VZV, strain Dumas) RIR2 89-101, YIEQECIEVVHAR

    HHV 3 (VZV, strain Dumas) RIR2 89-101, YIEQECIEVVHAR

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Herpes zoster Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Varicella-zoster virus (VZV) Protein Name: Ribonucleoside-diphosphate reductase Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-YIEQECIEVVHAR-OH Specifications: 13mer peptide as TFA salt

  • HHV 3 (VZV, strain Dumas) RIR2 9-21, FFYRPECPDINNL

    HHV 3 (VZV, strain Dumas) RIR2 9-21, FFYRPECPDINNL

    Application: T-cell immunity Category: Antigen Peptides Condition / Topic: Herpes zoster Layout: Freeze-dried in glass vial, Freeze-dried in plastic vial Organism: Varicella-zoster virus (VZV) Protein Name: Ribonucleoside-diphosphate reductase Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS) Quantification: No Sequence: H-FFYRPECPDINNL-OH Specifications: 13mer peptide as TFA salt